CMA1 and obesity due to melanocortin 4 receptor deficiency: Therefore, future studies are required to assess whether MC-derived, circulating blood biomarkers, such as serum tryptase and/or chymase levels, could be clinically used to estimate visceral AT-MC accumulation and obesity sub-types.